SCHEMBL14877516

SCHEMBL14877516

CC1CC(OC(=O)N2CCc3ccccc3C2)CN1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.49
ABHD6 Q9BV23 1/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
MAPT P10636 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
HSD11B1 P28845 1/20 0.44
HPGD P15428 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KEAP1 Q14145 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.43
ACHE P22303 1/20 0.42
PRMT5 O14744 3/20 0.42
WDR77 Q9BQA1 3/20 0.42
HRH3 Q9Y5N1 1/20 0.41
ACE P12821 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8278742 0.86 NOTUM (0.50) NOTUMABHD6KMT2AMEN1MAPT
SCHEMBL2608464 0.86 NOTUM (0.47) NOTUMABHD6KMT2AMEN1MAPT
SCHEMBL8253789 0.84 NOTUM (0.45) NOTUMABHD6KMT2AMEN1MAPT
SCHEMBL2608458 0.84 NOTUM (0.45) NOTUMABHD6KMT2AMEN1MAPT
SCHEMBL2102201 0.84 NOTUM (0.45) NOTUMABHD6KMT2AMEN1MAPT
SCHEMBL2102200 0.84 NOTUM (0.45) NOTUMABHD6KMT2AMEN1MAPT
SCHEMBL22784355 0.81 NOTUM (0.55) NOTUMABHD6KMT2AMEN1MAPT
SCHEMBL30132306 0.80 NOTUM (0.57) NOTUMABHD6KMT2AMEN1MAPT
SCHEMBL13951292 0.80 CHRM4 (0.52) NOTUMABHD6KMT2AMEN1MAPT
SCHEMBL12164334 0.80 TRAP1 (0.39) ABHD6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426359-B2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-04-23 US disclosed